• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

BRAF as a potential therapeutic target in melanoma and other malignancies.

作者信息

Tuveson David A, Weber Barbara L, Herlyn Meenhard

机构信息

Abramson Family Cancer Research Institute, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.

出版信息

Cancer Cell. 2003 Aug;4(2):95-8. doi: 10.1016/s1535-6108(03)00189-2.

DOI:10.1016/s1535-6108(03)00189-2
PMID:12957284
Abstract
摘要

相似文献

1
BRAF as a potential therapeutic target in melanoma and other malignancies.BRAF作为黑色素瘤及其他恶性肿瘤的潜在治疗靶点。
Cancer Cell. 2003 Aug;4(2):95-8. doi: 10.1016/s1535-6108(03)00189-2.
2
Relief of inhibitory autophosphorylation activates RAF.抑制性自动磷酸化的解除激活 RAF。
Cancer Discov. 2013 Jul;3(7):OF31. doi: 10.1158/2159-8290.CD-RW2013-110. Epub 2013 May 23.
3
A genome-based strategy uncovers frequent BRAF mutations in melanoma.一种基于基因组的策略揭示了黑色素瘤中频繁出现的BRAF突变。
Cancer Cell. 2002 Jul;2(1):5-7. doi: 10.1016/s1535-6108(02)00089-2.
4
RAF proteins exert both specific and compensatory functions during tumour progression of NRAS-driven melanoma.RAF 蛋白在 NRAS 驱动的黑色素瘤肿瘤进展过程中发挥特异性和补偿性功能。
Nat Commun. 2017 May 12;8:15262. doi: 10.1038/ncomms15262.
5
SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant.SPRY2是野生型BRAF黑色素细胞和黑色素瘤细胞中ras/细胞外信号调节激酶途径的抑制剂，但对V599E突变体则无此作用。
Cancer Res. 2004 Aug 15;64(16):5556-9. doi: 10.1158/0008-5472.CAN-04-1669.
6
The Brn-2 transcription factor links activated BRAF to melanoma proliferation.Brn-2转录因子将激活的BRAF与黑色素瘤增殖联系起来。
Mol Cell Biol. 2004 Apr;24(7):2923-31. doi: 10.1128/MCB.24.7.2923-2931.2004.
7
Lucky draw in the gene raffle.基因抽奖中的幸运抽奖。
Nature. 2002 Jun 27;417(6892):906-7. doi: 10.1038/417906a.
8
Loitering with intent: new evidence for the role of BRAF mutations in the proliferation of melanocytic lesions.蓄意徘徊：BRAF 突变在黑素细胞病变增殖中作用的新证据
J Invest Dermatol. 2004 Oct;123(4):xvi-xvii. doi: 10.1111/j.0022-202X.2004.23430.x.
9
C-Raf inhibits MAPK activation and transformation by B-Raf(V600E).C-Raf 抑制 B-Raf(V600E)的 MAPK 激活和转化。
Mol Cell. 2009 Nov 13;36(3):477-86. doi: 10.1016/j.molcel.2009.10.017.
10
Microarray expression profiling in melanoma reveals a BRAF mutation signature.黑色素瘤中的基因芯片表达谱分析揭示了一种BRAF突变特征。
Oncogene. 2004 May 20;23(23):4060-7. doi: 10.1038/sj.onc.1207563.

引用本文的文献

1
3,5-Disubstituted pyrazoline as a promising core for anticancer agents: mechanisms of action and therapeutic potentials.3,5-二取代吡唑啉作为一种有前景的抗癌药物核心结构：作用机制与治疗潜力
Future Med Chem. 2025 Mar;17(6):725-745. doi: 10.1080/17568919.2025.2476393. Epub 2025 Mar 13.
2
Rare malignant neoplasm of the esophagus: current status and future perspectives.食管罕见恶性肿瘤：现状与未来展望。
Jpn J Clin Oncol. 2024 Feb 7;54(2):111-120. doi: 10.1093/jjco/hyad144.
3
Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance.
激酶组分析预测黑色素瘤对MAPK抑制的敏感性并为内在和获得性耐药机制提供新见解。
Cancers (Basel). 2020 Feb 22;12(2):512. doi: 10.3390/cancers12020512.
4
Low dose radiation regulates BRAF-induced thyroid cellular dysfunction and transformation.低剂量辐射调节 BRAF 诱导的甲状腺细胞功能障碍和转化。
Cell Commun Signal. 2019 Feb 13;17(1):12. doi: 10.1186/s12964-019-0322-x.
5
Spotlight on dabrafenib/trametinib in the treatment of non-small-cell lung cancer: place in therapy.达拉非尼/曲美替尼治疗非小细胞肺癌的聚焦：治疗地位
Cancer Manag Res. 2018 Apr 3;10:647-652. doi: 10.2147/CMAR.S142269. eCollection 2018.
6
Bisarylureas Based on 1H-Pyrazolo[3,4-d]pyrimidine Scaffold as Novel Pan-RAF Inhibitors with Potent Anti-Proliferative Activities: Structure-Based Design, Synthesis, Biological Evaluation and Molecular Modelling Studies.基于1H-吡唑并[3,4-d]嘧啶骨架的双芳基脲类化合物作为具有强效抗增殖活性的新型泛RAF抑制剂：基于结构的设计、合成、生物学评价及分子模拟研究
Molecules. 2017 Mar 29;22(4):542. doi: 10.3390/molecules22040542.
7
Effects of nuclear factor-κB and ERK signaling transduction pathway inhibitors on human melanoma cell proliferation .核因子-κB和ERK信号转导通路抑制剂对人黑色素瘤细胞增殖的影响
Oncol Lett. 2015 Nov;10(5):3233-3237. doi: 10.3892/ol.2015.3672. Epub 2015 Sep 3.
8
An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors.作为B-Raf激酶抑制剂的咪唑并吡啶类化合物的分子对接和分子动力学模拟研究
Int J Mol Sci. 2015 Nov 16;16(11):27350-61. doi: 10.3390/ijms161126026.
9
The c-Jun/RHOB/AKT pathway confers resistance of BRAF-mutant melanoma cells to MAPK inhibitors.c-Jun/RHOB/AKT信号通路赋予BRAF突变型黑色素瘤细胞对MAPK抑制剂的抗性。
Oncotarget. 2015 Jun 20;6(17):15250-64. doi: 10.18632/oncotarget.3888.
10
A Combined Pharmacophore Modeling, 3D QSAR and Virtual Screening Studies on Imidazopyridines as B-Raf Inhibitors.作为B-Raf抑制剂的咪唑并吡啶类化合物的联合药效团建模、三维定量构效关系及虚拟筛选研究
Int J Mol Sci. 2015 May 29;16(6):12307-23. doi: 10.3390/ijms160612307.